Literature DB >> 6311251

19-nor-10-ketovitamin D derivatives: unique metabolites of vitamin D3, vitamin D2, and 25-hydroxyvitamin D3.

J L Napoli, J L Sommerfeld, B C Pramanik, R Gardner, A D Sherry, J J Partridge, M R Uskokovic, R L Horst.   

Abstract

Three metabolites were isolated after incubation of vitamin D3, vitamin D2, or 25-hydroxyvitamin D3 with bovine rumen microbes. They are identified as 5(E)-19-nor-10-ketovitamin D3, 5(E)-19-nor-10-ketovitamin D2, and 5(E)-19-nor-10-keto-25-hydroxyvitamin D3, respectively. The identifications were based on ultraviolet absorbance, mass spectroscopy, and chemical reactivity. All 5(E)-19-nor-10-ketovitamin D derivatives examined had an absorbance maximum at 312 nm and a characteristic fragment in their mass spectra corresponding to loss of 43 amu from their molecular ions. The vitamin D3 metabolite was identical in all essential spectral and chromatographic aspects with authentic synthetic 5(E)-19-nor-10-ketovitamin D3. These metabolites represent a unique pathway of vitamin D metabolism and the first characterized products of microbial vitamin D metabolism. The conversion of vitamin D and its metabolites to their 19-nor-10-keto forms likely represents a detoxification mechanism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311251     DOI: 10.1021/bi00284a015

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Phagocytic cells synthesize 19-nor-10-keto-25-hydroxyvitamin D3, a metabolite that may induce differentiation of the human monoblastic cell line U937.

Authors:  T K Gray; D S Millington; D A Maltby; M E Williams; M S Cohen; R C Dodd
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

2.  Metabolism of 20-hydroxyvitamin D3 by mouse liver microsomes.

Authors:  Chloe Y S Cheng; Andrzej T Slominski; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2014-08-17       Impact factor: 4.292

3.  1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis.

Authors:  J Cadranel; M Garabedian; B Milleron; H Guillozo; G Akoun; A J Hance
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

4.  25-Hydroxyvitamin D3 metabolism in a human leukemia cell line.

Authors:  Z Bar-Shavit; R L Horst; J C Chappel; F P Ross; R W Gray; S L Teitelbaum
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

Review 5.  Potent 19-norvitamin D analogs for prostate and liver cancer therapy.

Authors:  Atsushi Kittaka; Akihiro Yoshida; Kun-Chun Chiang; Masashi Takano; Daisuke Sawada; Toshiyuki Sakaki; Tai C Chen
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

6.  Novel vitamin d analogs for prostate cancer therapy.

Authors:  Tai C Chen; Atsushi Kittaka
Journal:  ISRN Urol       Date:  2011-09-19

7.  The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential.

Authors:  Kun-Chun Chiang; Ta-Sen Yeh; Shin-Cheh Chen; Jong-Hwei S Pang; Chun-Nan Yeh; Jun-Te Hsu; Li-Wei Chen; Sheng-Fong Kuo; Masashi Takano; Atsushi Kittaka; Tai C Chen; Chi-Chin Sun; Horng-Heng Juang
Journal:  Int J Mol Sci       Date:  2016-04-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.